TipRanks
Advertisement
Advertisement
TriSalus Life Sciences initiated with a Buy at H.C. Wainwright
PremiumThe FlyTriSalus Life Sciences initiated with a Buy at H.C. Wainwright
1M ago
TriSalus Life Sciences: Buy Rating Reaffirmed with Unchanged $7 Price Target Despite Near-Term Covenant Risks
Premium
Ratings
TriSalus Life Sciences: Buy Rating Reaffirmed with Unchanged $7 Price Target Despite Near-Term Covenant Risks
2M ago
Analyst Justin Walsh Reaffirms Buy on TriSalus After Strong Q2 Results, CMS Reimbursement Tailwinds, and Growth Outlook Through 2026
Premium
Ratings
Analyst Justin Walsh Reaffirms Buy on TriSalus After Strong Q2 Results, CMS Reimbursement Tailwinds, and Growth Outlook Through 2026
2M ago
TriSalus Stockholders Back Directors, Auditor and Pay Policies
PremiumCompany AnnouncementsTriSalus Stockholders Back Directors, Auditor and Pay Policies
5M ago
TriSalus Life Sciences Bets Big Amid FDA Delay
Premium
Company Announcements
TriSalus Life Sciences Bets Big Amid FDA Delay
5M ago
TriSalus Life Sciences price target lowered to $8 from $10 at Lake Street
Premium
The Fly
TriSalus Life Sciences price target lowered to $8 from $10 at Lake Street
5M ago
TriSalus Life Sciences Names Richard Marshall Chief Medical Officer
PremiumCompany AnnouncementsTriSalus Life Sciences Names Richard Marshall Chief Medical Officer
6M ago
TriSalus Life Sciences price target lowered to $8 from $12.50 at Northland
Premium
The Fly
TriSalus Life Sciences price target lowered to $8 from $12.50 at Northland
7M ago
TriSalus: Versatile PEDD Platform, Compelling Nelitolimod Data, and Expanding TriNav Revenue Support Buy Rating
Premium
Ratings
TriSalus: Versatile PEDD Platform, Compelling Nelitolimod Data, and Expanding TriNav Revenue Support Buy Rating
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―